E6011 Safe & Well Tolerated in RA Patients Michele B. Kaufman, PharmD, BCGP | December 18, 2017E6011, an anti-fractalkine monoclonal antibody, proved promising for the treatment of rheumatoid arthritis during a 52-week clinical trial…